P-288Global Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Compare Efficacy and Safety of PEGylated Recombinant Human Hyaluronidase (PEGPH20) Plus nab-Paclitaxel and Gemcitabine vs. Placebo Plus nab-Paclitaxel and Gemcitabine

ABSTRACT:

SUBMITTER: Margaret T 

PROVIDER: S-EPMC4984075 | biostudies-literature | 2016 Jun

REPOSITORIES: biostudies-literature